Deplin costs roughly $370 for a 90-day supply at retail, putting it well above what most people expect to pay for what is essentially a B vitamin. The price stems from a combination of its regulatory classification, patent protection, and the lack of insurance coverage that typically accompanies products in its category. The good news: alternatives exist at a fraction of the cost.
What Deplin Actually Is
Deplin contains l-methylfolate, the active form of folate (vitamin B9) that your body can use directly. Most people convert regular folic acid into this active form on their own, but up to 70% of people with depression or schizophrenia carry gene variants that impair that conversion. The most well-known is the MTHFR C677T variant. For these individuals, supplementing with the pre-converted form at clinical doses (7.5 mg or 15 mg per day) can meaningfully reduce depressive symptoms, particularly when standard antidepressants alone aren’t working well enough.
That’s the clinical rationale. But l-methylfolate is not a novel molecule. It occurs naturally in leafy greens, and multiple companies sell it. So why does the branded version cost so much?
The “Medical Food” Loophole
Deplin is classified as a medical food, not a prescription drug and not a dietary supplement. Under federal law, a medical food is “formulated to be consumed under the supervision of a physician” for “the specific dietary management of a disease or condition for which distinctive nutritional requirements are established by medical evaluation.” This definition comes from the Orphan Drug Act and is enforced by the FDA.
This classification creates an unusual pricing situation. Medical foods don’t go through the rigorous (and expensive) FDA drug approval process, which means lower development costs for the manufacturer. But they also don’t face the same competitive pressures as over-the-counter supplements, because they’re marketed through doctors and prescribed on a pad. Patients treat them like prescriptions, and the pricing reflects that expectation. The manufacturer, Alfasigma, positions Deplin as a clinical-grade product distinct from supplement-aisle alternatives, which supports a premium price point.
Patent Protection Until 2030
Alfasigma holds multiple U.S. patents on Deplin, with expiration dates in early and mid-2030. These patents don’t cover l-methylfolate itself (which can’t be patented as a naturally occurring compound) but rather specific formulations, dosing configurations, or delivery methods. Until those patents expire, no company can sell a product marketed as a generic version of Deplin specifically. This limits direct competition within the medical food channel and keeps prices elevated.
Insurance Rarely Covers It
Here’s where the medical food classification hurts consumers most. Because Deplin is not an FDA-approved drug, most insurance plans and pharmacy benefit managers don’t cover it. Medicare Part D generally excludes medical foods entirely. That means the full retail price lands on the patient. A 90-capsule supply (either the 7.5 mg or 15 mg strength) runs about $369 at retail, which works out to roughly $123 per month.
Alfasigma offers a Brand Direct Health Program that can bring the cost down to $66 per month with home delivery for eligible patients. That’s a significant discount, but still far above what generic alternatives cost.
Generic L-Methylfolate Costs Far Less
The same active ingredient is available as generic l-methylfolate from other manufacturers. These products aren’t branded as “Deplin,” but they contain the same molecule at the same doses. The price difference is dramatic.
- Generic 15 mg tablets (30-count): Around $31 with a discount coupon, compared to Deplin’s roughly $123 per month
- Generic 7.5 mg tablets (30-count): Around $36 with a discount coupon
Generic l-methylfolate capsules (the same form factor as Deplin) cost more, running $140 to $290 for 90 capsules depending on the dose. But the tablet versions deliver the same active ingredient at a quarter of Deplin’s price or less. Pharmacy discount programs like GoodRx regularly offer these lower prices without insurance.
Over-the-counter l-methylfolate supplements are also available at even lower prices, though these typically come in much smaller doses (usually 400 mcg to 1 mg) compared to the 7.5 or 15 mg clinical doses used alongside antidepressants. If your doctor has prescribed a high-dose product, a standard supplement-aisle version won’t deliver the same amount.
Why Doctors Still Prescribe the Brand
Some physicians continue writing for Deplin by name for a few reasons. The medical food classification means it’s marketed directly to clinicians with clinical data supporting its specific formulation. Doctors may be more familiar with the brand than with generic alternatives, or they may trust the manufacturing consistency of a product sold through pharmacy channels rather than the supplement market, which has less regulatory oversight. Some patients also report that their pharmacy can only order the brand when a prescription is written for “Deplin” rather than “l-methylfolate.”
If cost is a concern, asking your prescriber to write for generic l-methylfolate by name, at the same dose, opens the door to significantly cheaper options. A pharmacist can also help identify which generic versions are available at your local pharmacy and what the out-of-pocket cost would be with a discount card.